Data / Form D filings / Intezyne Technologies, Inc.
Intezyne Technologies, Inc.: Form D filings
Intezyne Technologies, Inc., a pharmaceuticals company in Tampa, FL, filed 2 Form D notices with the SEC between 2013 and 2016. The latest, on June 9, 2016, reports $480,000 sold of a $12 million offering to 1 investor.
Find out what Intezyne Technologies, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3720 SPECTRUM BOULEVARD, SUITE 104, Tampa, FL, 33612
- Phone
- (813) 910-2120
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1580048
The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 9, 2016 | New notice | $12,000,000 | $480,000 | $11,520,000 | 1 | May 25, 2016 | sec.gov |
| Jun 25, 2013 | New notice | $8,844,359 | $8,844,359 | $0 | 52 | Jun 10, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Cole | Director | |
| Kevin Sill | Executive Officer | |
| Daniel Devers | Executive Officer | |
| Carolyn Paradise | Executive Officer | |
| Michael Fountain | Director | |
| John McBride | Director | |
| Hooshmand Sheshbaradaran | Director |
Other pharmaceuticals companies in Florida that filed recently
- GOA Therapeutics Corp $300,000 · Nov 5, 2026
- DalCor Pharmaceuticals US, LLC $7 million · Aug 28, 2026
Every Form D from the week of Jun 6, 2016 · All recent filings in Florida · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Intezyne Technologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.